MARKET

NRSNW

NRSNW

Neurosense Therapeutics Ltd
NASDAQ
0.3000
+0.1500
+100.00%
Closed 16:00 11/27 EST
OPEN
0.2400
PREV CLOSE
0.1500
HIGH
0.3000
LOW
0.1701
VOLUME
3.13K
TURNOVER
--
52 WEEK HIGH
0.6500
52 WEEK LOW
0.0730
MARKET CAP
--
P/E (TTM)
-0.6831
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NRSNW last week (1118-1122)?
Weekly Report · 3d ago
BRIEF-Neurosense Therapeutics Files For Offering Of Up To 10 Million Ordinary Shares
Reuters · 11/19 22:25
Weekly Report: what happened at NRSNW last week (1111-1115)?
Weekly Report · 11/18 09:55
Weekly Report: what happened at NRSNW last week (1104-1108)?
Weekly Report · 11/11 10:01
Weekly Report: what happened at NRSNW last week (1028-1101)?
Weekly Report · 11/04 10:00
NEUROSENSE: IN CANADA, PLANS TO SUBMIT DOSSIER IN Q2 2025, WITH REGULATORY DECISION ON COMMERCIALIZATION EXPECTED BY Q1 2026
Reuters · 10/28 12:31
Weekly Report: what happened at NRSNW last week (1021-1025)?
Weekly Report · 10/28 09:57
Neurosense Therapeutics Ltd: Report of foreign issuer
Press release · 10/25 12:10
More
About NRSNW
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease

Webull offers Neurosense Therapeutics Ltd stock information, including NASDAQ: NRSNW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRSNW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRSNW stock methods without spending real money on the virtual paper trading platform.